Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Prepaid Assets (2019 - 2025)

Eton Pharmaceuticals' Prepaid Assets history spans 7 years, with the latest figure at $4.9 million for Q3 2025.

  • For Q3 2025, Prepaid Assets rose 152.27% year-over-year to $4.9 million; the TTM value through Sep 2025 reached $4.9 million, up 152.27%, while the annual FY2024 figure was $5.5 million, 386.45% up from the prior year.
  • Prepaid Assets for Q3 2025 was $4.9 million at Eton Pharmaceuticals, up from $4.8 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $5.5 million in Q4 2024 and bottomed at $541000.0 in Q3 2023.
  • The 5-year median for Prepaid Assets is $1.7 million (2021), against an average of $2.2 million.
  • The largest annual shift saw Prepaid Assets crashed 59.4% in 2022 before it soared 503.25% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $3.2 million in 2021, then plummeted by 59.4% to $1.3 million in 2022, then decreased by 12.48% to $1.1 million in 2023, then skyrocketed by 386.45% to $5.5 million in 2024, then fell by 10.01% to $4.9 million in 2025.
  • Per Business Quant, the three most recent readings for ETON's Prepaid Assets are $4.9 million (Q3 2025), $4.8 million (Q2 2025), and $2.5 million (Q1 2025).